Is Hoth Therapeutics Inc (HOTH) overvalued? · rev $1.24B
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
This page asks whether Hoth Therapeutics Inc (HOTH) looks expensive on cached numbers — not a short thesis.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
HOTH currently screens at market cap $15.5M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next HOTH 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the HOTH stock page for the full model, not this heading.
Not investment advice.